Circulating miR-142-3p levels in patients with systemic sclerosis

Korn, 1989, Immunologic aspects of scleroderma, Curr Opin Rheumatol, 1, 479, 10.1097/00002281-198901040-00011

Mauch, 1990, Fibroblast-matrix interactions and their role in the pathogenesis of fibrosis, Rheum Dis Clin North Am, 16, 93, 10.1016/S0889-857X(21)01042-5

Mauch, 1992, Altered regulation of collagen metabolism in scleroderma fibroblasts grown within three-dimensional collagen gels, Exp Dermatol, 1, 185, 10.1111/j.1600-0625.1992.tb00187.x

Jelaska, 1996, Heterogeneity of collagen synthesis in normal and systemic sclerosis skin fibroblasts. Increased proportion of high collagen-producing cells in systemic sclerosis fibroblasts, Arthritis Rheum, 39, 1338, 10.1002/art.1780390811

Leroy, 1989, A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor beta the answer?, Arthritis Rheum, 32, 817, 10.1002/j.2326-5205.1989.tb00012.x

LeRoy, 1974, Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast, J Clin Invest, 54, 880, 10.1172/JCI107827

Jimenez, 1986, Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis fibroblasts, Biochem J, 237, 837, 10.1042/bj2370837

Kikuchi, 1992, Direct demonstration of transcriptional activation of collagen gene expression in systemic sclerosis fibroblasts: insensitivity to TGF beta 1 stimulation, Biochem Biophys Res Commun, 187, 45, 10.1016/S0006-291X(05)81456-1

Lyons, 1990, Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin, J Cell Biol, 110, 1361, 10.1083/jcb.110.4.1361

Ihn, 2002, The role of TGF-beta signaling in the pathogenesis of fibrosis in scleroderma, Arch Immunol Ther Exp (Warsz), 50, 325

Asano, 2006, Increased expression of integrin alphaVbeta5 induces the myofibroblastic differentiation of dermal fibroblasts, Am J Pathol, 168, 499, 10.2353/ajpath.2006.041306

Murphy-Ullrich, 2000, Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology, Cytokine Growth Factor Rev, 11, 59, 10.1016/S1359-6101(99)00029-5

Ihn, 2001, Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors, Arthritis Rheum, 44, 474, 10.1002/1529-0131(200102)44:2<474::AID-ANR67>3.0.CO;2-#

Asano, 2005, Involvement of alphaVbeta5 integrin-mediated activation of latent transforming growth factor beta1 in autocrine transforming growth factor beta signaling in systemic sclerosis fibroblasts, Arthritis Rheum, 52, 2897, 10.1002/art.21246

Lewis, 2005, Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets, Cell, 120, 15, 10.1016/j.cell.2004.12.035

LeRoy, 1988, Scleroderma (systemic sclerosis): classification, subsets and pathogenesis, J Rheumatol, 15, 202

Ihn, 1996, Measurement of anticardiolipin antibodies by ELISA using beta 2-glycoprotein I (beta 2-GPI) in systemic sclerosis, Clin Exp Immunol, 105, 475, 10.1046/j.1365-2249.1996.d01-774.x

Maricq, 1990, Major clinical diagnoses found among patients with Raynaud phenomenon from the general population, J Rheumatol, 17, 1171

Ihn, 1992, Clinical evaluation of scleroderma spectrum disorders using a points system, Arch Dermatol Res, 284, 391, 10.1007/BF00372068

Maricq, 1989, Prevalence of scleroderma spectrum disorders in the general population of South Carolina, Arthritis Rheum, 32, 998, 10.1002/anr.1780320809

Kroh, 2010, Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR), Methods, 50, 298, 10.1016/j.ymeth.2010.01.032